RMC No. 112-2022: FDA-Endorsed Updates to VAT-Exempt Medicines Affecting Tuberculosis Treatments

RMC No. 112-2022 updates the VAT-exempt medicines list under the CREATE Act, adding tuberculosis medicines and removing COVID-19 medicines, affecting tax compliance for healthcare providers. Businesses in the pharmaceutical and healthcare sectors must immediately update their records and compliance processes due to the newly endorsed changes to the VAT-exempt medicines list. Certain medicines prescribed for […]

RMC No. 66-2022: Updated VAT-Exempt Medical Devices for COVID-19 Treatment Under the CREATE Act

RMC No. 66-2022 updates the FDA-endorsed VAT-exempt list for certain COVID-19 treatment medical devices under the CREATE Act. Businesses selling, importing, purchasing, or claiming VAT treatment on COVID-19-related medical devices must immediately check whether their products remain covered by the updated VAT-exempt list endorsed by the Food and Drug Administration. RMC No. 66-2022 matters because […]

RMC No. 42-2021: BIR Circularizes the CREATE Act and Corporate Tax Reform Guidance for Philippine Businesses

RMC No. 42-2021 circularizes the CREATE Act and veto message, requiring businesses to review corporate tax, VAT, withholding, and incentive compliance. Corporate taxpayers should immediately review their income tax, withholding tax, VAT-exempt transaction, percentage tax, tax incentive, refund or remission, and tax assessment workflows because RMC No. 42-2021 places Republic Act No. 11534, known as […]